MustGrow Operating Cycle from 2010 to 2025

Stocks . Canada . 
Stock . MustGrow Biologics Corp
MGRO Stock   0.65  0.02  2.99%   
MustGrow Biologics Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle is likely to outpace its year average in 2025. During the period from 2010 to 2025, MustGrow Biologics Operating Cycle regression line of quarterly data had mean square error of 2.4 M and geometric mean of  1,060. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
5.5 K
Current Value
5.7 K
Quarterly Volatility
2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MustGrow Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MustGrow Biologics' main balance sheet or income statement drivers, such as Net Interest Income of 212.5 K, Interest Expense of 0.0 or Selling General Administrative of 3.7 M, as well as many indicators such as Price To Sales Ratio of 142, Dividend Yield of 0.0 or PTB Ratio of 28.72. MustGrow financial statements analysis is a perfect complement when working with MustGrow Biologics Valuation or Volatility modules.
  
This module can also supplement various MustGrow Biologics Technical models . Check out the analysis of MustGrow Biologics Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MustGrow Stock Analysis

When running MustGrow Biologics' price analysis, check to measure MustGrow Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MustGrow Biologics is operating at the current time. Most of MustGrow Biologics' value examination focuses on studying past and present price action to predict the probability of MustGrow Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MustGrow Biologics' price. Additionally, you may evaluate how the addition of MustGrow Biologics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY